Mineralys Therapeutics Inc. Common Stock (MLYS) Insider Trading
- $32,705,550.00
- $11,954,084.77
- Nov. 6, 2024
- Jon Congleton
| Trader Name | Date | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|---|
| Nov. 6, 2024 | Insider | 25,482 | $15.03 | Sell | $382,994.46 | |
| Oct. 11, 2024 | CFO | 10,757 | $13.57 | Sell | $145,972.49 | |
| Oct. 11, 2024 | CEO | 15,271 | $13.52 | Sell | $206,463.92 | |
| July 24, 2024 | Director | 550,000 | $13.05 | Sell | $7,177,500.00 | |
| July 16, 2024 | Insider | 525 | $15.00 | Sell | $7,875.00 | |
| July 11, 2024 | CEO | 15,746 | $13.34 | Sell | $210,051.64 | |
| July 11, 2024 | CFO | 10,757 | $13.14 | Sell | $141,346.98 | |
| June 14, 2024 | CEO | 16,229 | $12.52 | Sell | $203,187.08 | |
| June 12, 2024 | CEO | 16,607 | $12.77 | Sell | $212,071.39 | |
| June 11, 2024 | CFO | 96,815 | $12.94 | Sell | $1,252,786.10 | |
| May 9, 2024 | Insider | 100 | $15.00 | Sell | $1,500.00 | |
| Feb. 12, 2024 | Major Shareholder | 555,555 | $13.50 | Buy | $7,499,992.50 | |
| Nov. 22, 2023 | CEO | 4,250 | $5.97 | Buy | $25,372.50 | |
| Sept. 6, 2023 | CEO | 2,250 | $12.08 | Buy | $27,180.00 | |
| Aug. 17, 2023 | CEO | 2,250 | $12.10 | Buy | $27,225.00 | |
| Aug. 11, 2023 | insider | 157,091 | $12.81 | Sell | $2,012,335.71 | |
| Aug. 11, 2023 | CEO | 2,000 | $12.89 | Buy | $25,780.00 | |
| Feb. 14, 2023 | Major Shareholder | 312,500 | $16.00 | Buy | $5,000,000.00 | |
| Feb. 14, 2023 | Director | 1,250,000 | $16.00 | Buy | $20,000,000.00 | |
| Feb. 14, 2023 | CFO | 6,250 | $16.00 | Buy | $100,000.00 |
Insiders are both buying and selling Mineralys Therapeutics Inc. Common Stock stock.
The insider traders at Mineralys Therapeutics Inc. Common Stock are: Jon Congleton, David Malcom Rodman, Adam Scott Levy, Samsara Biocapital Gp, Llc, Hbm Healthcare Investments (Ca, Brian Taylor Slingsby, and Ra Capital Management, L.P.
The most active insider trader at Mineralys Therapeutics Inc. Common Stock is Jon Congleton with 8 trades.
Brian Taylor Slingsby has sold the most Mineralys Therapeutics Inc. Common Stock stock with a total value of $14,355,000.00.
Ra Capital Management, L.P. has bought the most Mineralys Therapeutics Inc. Common Stock stock with a total value of $40,000,000.00.
The most recent insider trade for Mineralys Therapeutics Inc. Common Stock was on Nov. 6, 2024.
The single biggest insider buy for Mineralys Therapeutics Inc. Common Stock was from Ra Capital Management, L.P. with a total value of $20,000,000.00 on Feb. 14, 2023.
The single biggest insider sell for Mineralys Therapeutics Inc. Common Stock was from Brian Taylor Slingsby with a total value of $7,177,500.00 on July 24, 2024.